XM does not provide services to residents of the United States of America.

U.S. STOCKS Smartsheet, Bowlero, Samsara



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-U.S. STOCKS ON THE MOVE-Smartsheet, Bowlero, Samsara</title></head><body>

Eikon search string for individual stock moves: STXBZ

The Day Ahead newsletter: https://refini.tv/3LI4BU7

The Morning News Call newsletter: https://refini.tv/3dKUyB8

Wall Street's main indexes were set to open flat to slightly lower after a report showed fewer-than-expected jobs additions in the previous month, aiding expectations that the Federal Reserve will deliver an upsized interest rate cut in September. .N


At 9:14 ET, Dow e-minis 1YMc1 were unchanged at 40,831. S&P 500 e-minis ESc1 were up 0.06% at 5,515.75, while Nasdaq 100 e-minis NQc1 were down 0.15% at 18,935.25.

The top three NYSE percentage gainers premarket .PRPG.NQ:
** Argan AGX.N, up 24%
** Quanex Building Products NX.N, up 18.5%
** Guidewire Software GWRE.N, up 12.0%

The top three NYSE percentage losers premarket .PRPL.NQ:
** Planet Labs PL.N, down 7.7%
** BIT Mining BTCM.N, down 7.1%
** Similarweb SMWB.N, down 6.7%

The top two Nasdaq percentage gainers premarket .PRPG.O:
** Wheeler Real Estate Investment Trust WHLR.O, up 120.0%
** BloomZ BLMZ.O, up 72.0%

** Planet Labs PL.N: down 7.7% premarket
BUZZ - Slumps after forecasting Q3 rev below estimates nL4N3KO0M6


** Samsara IOT.N: up 6.1% premarket
BUZZ - Gains after lifting annual revenue forecast nL4N3KO0LY


** Broadcom AVGO.O: down 6.4% premarket
BUZZ - Slips on downbeat Q4 revenue forecast nL4N3KO0NG


** Travere Therapeutics TVTX.O: up 6.9% premarket
BUZZ - Rises on US FDA's full approval for kidney disease therapy []


** Bloom Energy BE.N: down 5.5% premarket
BUZZ - Falls after Jefferies downgrades to 'hold' nL4N3KO0PH


** Smith & Wesson Brands SWBI.O: down 3.1% premarket
BUZZ - Falls after Q1 rev miss on soft demand nL1N3KO0C4


** Mobileye Global MBLY.O: down 3.7% premarket
BUZZ - Falls after report says Intel exploring stake sale nL4N3KO0SZ


** Smartsheet SMAR.N: up 6.3% premarket
BUZZ - Rises on upbeat forecast, Q2 results beat nL4N3KO0TV


** AvalonBay Communities AVB.N: down 1.8% premarket
BUZZ - Drops on pricing $710 mln stock deal nL1N3KO0E7


** Bowlero BOWL.N: up 10.9% premarket
BUZZ - Climbs on Q4 revenue beat nL4N3KO0V0


** Core Scientific CORZ.O: down 0.6% premarket
BUZZ - CFO to step down; shares fall nL4N3KO0VN


** Amneal Pharmaceuticals AMRX.O: up 1.4% premarket
BUZZ - Rises after J.P. Morgan upgrades to 'neutral' on strength in generics unit nL4N3KO0X1


** Super Micro Computer SMCI.O: down 2.2% premarket
BUZZ - Slips after JP Morgan downgrades to "neutral", hacks PT nL1N3KO0HW


(Rajarshi Roy and Anuja Bharat Mistry)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.